1
Clinical Trials associated with Revottack / Unknown statusPhase 1IIT A Clinical Pharmacological Study of Intravenous Administration of Vesicular Stomatitis Oncolytic Virus Injection (Revottack)Combined PD-1 Inhibitor in Patients With Advanced Malignant Solid Tumor
This is a one arm, open clinical pharmacological exploration study initiated by researchers to evaluate the safety and effectiveness of vesicular stomatitis oncolytic virus injection (Revottack) combined with PD-1 inhibitor in patients with advanced malignant solid tumors.
The purpose of this study is to evaluate the safety, tolerability, anti-tumor activity, immunogenicity, immune response, pharmacokinetic (PK) characteristics and shedding characteristics of Revottack injection combined with PD-1 inhibitor in patients with advanced solid tumors.
100 Clinical Results associated with Revottack
100 Translational Medicine associated with Revottack
100 Patents (Medical) associated with Revottack
100 Deals associated with Revottack